|
|
||||||||
Journal of Lipid Research, Vol 37, 727-738, Copyright © 1996 by Lipid Research, Inc.
M Syvanne, M Antikainen, S Ehnholm, H Tenkanen, S Lahdenpera, C Ehnholm and MR Taskinen
We describe two Finnish kindreds with the Asn291 --> Ser mutation
(A291S) of the lipoprotein lipase (LPL) gene. Sixteen subjects (9 male, 7
female) heterozygous for this mutation were studied and compared with 17
unaffected family members or spouses (family controls) and 19 unrelated
healthy subjects (population controls). In the group of subjects
heterozygous for the A291S mutation, postheparin plasma LPL activity was on
average 23% lower than in the family controls and 29% lower than in the
population controls. In agreement, in vitro expression studies with COS-7
cells showed that the mutant protein exhibits approximately 50% of the
lipolytic activity of the wild-type protein. Median serum triglyceride
concentration was 2.90 mmol/l in the group of heterozygotes, compared with
1.14 mmol/l in the family controls (P < 0.01) and 0.99 mmol/l in the
population controls (P < 0.001). The heterozygotes also had a marked
preponderance of small dense low density lipoproteins (LDL) as assessed by
gradient gel electrophoresis. Nine of the heterozygous subjects were
hypertriglyceridemic (serum triglyceride concentration > 2.0 mmol/l).
Age or body mass index were not related to the presence of
hypertriglyceridemia. By contrast, all hypertriglyceridemic subjects were
either hyperinsulinemic (serum insulin concentration > 10 mU/l, n = 7)
or had diabetes (n = 2). In a multivariate regression analysis, very low
density lipoprotein (VLDL) triglyceride level was significantly and
independently related to serum apolipoprotein B concentration, the presence
of the A291S mutation, serum insulin concentration, and postheparin plasma
LPL activity. The Asn291-->Ser mutation of the LPL gene results in
reduced lipolytic activity. However, dyslipidemia appears to manifest only
if VLDL production is also increased. Hyperinsulinemia was the major
determinant of excessive VLDL synthesis and dyslipidemia among the subjects
heterozygous for the A291S mutation in this study.
ARTICLES
Heterozygosity for Asn291-->Ser mutation in the lipoprotein lipase gene in two Finnish pedigrees: effect of hyperinsulinemia on the expression of hypertriglyceridemia
Department of Medicine, Helsinki University, Central Hospital, Finland.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
Y. Hu, W. Liu, R. Huang, and X. Zhang A systematic review and meta-analysis of the relationship between lipoprotein lipase Asn291Ser variant and diseases J. Lipid Res., September 1, 2006; 47(9): 1908 - 1914. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Mero, L. Suurinkeroinen, M. Syvänne, P. Knudsen, H. Yki-Järvinen, and M.-R. Taskinen Delayed clearance of postprandial large TG-rich particles in normolipidemic carriers of LPL Asn291Ser gene variant J. Lipid Res., September 1, 1999; 40(9): 1663 - 1670. [Abstract] [Full Text] |
||||
![]() |
H. H. Wittrup, A. Tybjærg-Hansen, and B. G. Nordestgaard Lipoprotein Lipase Mutations, Plasma Lipids and Lipoproteins, and Risk of Ischemic Heart Disease : A Meta-Analysis Circulation, June 8, 1999; 99(22): 2901 - 2907. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.E. Miettinen, H. Gylling, J. Tenhunen, J. Virtamo, M. Jauhiainen, J.K. Huttunen, I. Kantola, T.A. Miettinen, and K. Kontula Molecular Genetic Study of Finns With Hypoalphalipoproteinemia and Hyperalphalipoproteinemia : A Novel Gly230Arg Mutation (LCATFin) of Lecithin:Cholesterol Acyltransferase (LCAT) Accounts for 5% of Cases With Very Low Serum HDL Cholesterol Levels Arterioscler. Thromb. Vasc. Biol., April 1, 1998; 18(4): 591 - 598. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Wittekoek, S. N. Pimstone, P. W. A. Reymer, L. Feuth, G.-J. Botma, J. C. Defesche, M. Prins, M. R. Hayden, and J. J. P. Kastelein A Common Mutation in the Lipoprotein Lipase Gene (N291S) Alters the Lipoprotein Phenotype and Risk for Cardiovascular Disease in Patients With Familial Hypercholesterolemia Circulation, March 3, 1998; 97(8): 729 - 735. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ehrenborg, S. M. Clee, S. N. Pimstone, P. W.A. Reymer, P. Benlian, C. F. Hoogendijk, H. J. Davis, N. Bissada, L. Miao, S. E. Gagne, et al. Ethnic Variation and In Vivo Effects of the -93t->g Promoter Variant in the Lipoprotein Lipase Gene Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2672 - 2678. [Abstract] [Full Text] |
||||
![]() |
B. G. Nordestgaard, S. Abildgaard, H. H. Wittrup, R. Steffensen, G. Jensen, and A. Tybjærg-Hansen Heterozygous Lipoprotein Lipase Deficiency : Frequency in the General Population, Effect on Plasma Lipid Levels, and Risk of Ischemic Heart Disease Circulation, September 16, 1997; 96(6): 1737 - 1744. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |